Skip to main content
. Author manuscript; available in PMC: 2023 Sep 2.
Published in final edited form as: Vaccine. 2022 Aug 10;40(37):5483–5493. doi: 10.1016/j.vaccine.2022.07.020

Table 5.

Factors associated with timely vaccination among rural children, 2015–16 TDHS-MIS

BCG OPV0 OPV1 Penta1 PCV1 Rota1 Measles#
N = 3,876 N = 4,054 N = 3,953 N = 3,994 N = 3,873 N = 3,882 N = 2,583
Risk factor aHR 95% CI aHR 95% CI aHR 95% CI aHR 95% CI aHR 95% CI aHR 95% CI aHR 95% CI
Distance to health facility 0.97 (0.96,0.98) 0.96 (0.94,0.97) 0.97 (0.96,0.98) 0.97 (0.96,0.98) 0.97 (0.96,0.98) 0.97 (0.97,0.98) 0.97 (0.96,0.98)
Wealth index score 1.20 (1.11,1.30) 1.20 (1.11,1.31) 1.15 (1.07,1.23) 1.23 (1.15,1.32) 1.21 (1.13,1.31) 1.15 (1.07,1.24) 1.17 (1.06,1.30)
Mother’s age at delivery 1.00 (1.00,1.01) 1.00 (0.99,1.01) 1.00 (1.00,1.01) 1.00 (1.00,1.01) 1.01 (1.00,1.01) 1.00 (1.00,1.01) 0.99 (0.98,1.00)
Mother’s education
 None Ref. Ref. Ref. Ref. Ref. Ref. Ref.
 Primary 1.14 (1.02,1.27) 1.03 (0.91,1.18) 1.35 (1.22,1.49) 1.32 (1.19,1.45) 1.27 (1.15,1.40) 1.28 (1.16,1.42) 1.19 (1.04,1.36)
 Secondary or higher 1.32 (1.10,1.58) 1.22 (1.00,1.49) 1.47 (1.25,1.73) 1.29 (1.09,1.51) 1.33 (1.12,1.56) 1.45 (1.23,1.70) 1.38 (1.11,1.72)
Birth order
 First child Ref. Ref. Ref. Ref. Ref. Ref. Ref.
 Second or higher 0.98 (0.87,1.11) 0.94 (0.81,1.08) 1.05 (0.94,1.18) 1.00 (0.89,1.12) 1.03 (0.92,1.16) 1.07 (0.95,1.20) 0.93 (0.81,1.08)
Antenatal care visits
 0–3 Ref. Ref. Ref. Ref. Ref. Ref. Ref.
 4 or more 1.00 (0.91,1.09) 1.02 (0.91,1.13) 1.01 (0.93,1.10) 1.01 (0.93,1.10) 1.05 (0.96,1.14) 1.04 (0.95,1.13) 1.03 (0.93,1.15)
 Unknown/missing 0.60 (0.31,1.18) 0.59 (0.26,1.31) 1.00 (0.51,1.98) 0.71 (0.36,1.42) 0.78 (0.33,1.84) 0.83 (0.34,2.05) 1.23 (0.74,2.07)
Tetanus Toxoid doses
 0 Ref. Ref. Ref. Ref. Ref. Ref. Ref.
 1 1.01 (0.90,1.14) 0.87 (0.75,1.01) 1.01 (0.91,1.12) 1.01 (0.91,1.13) 0.98 (0.88,1.10) 1.00 (0.89,1.12) 0.87 (0.75,1.01)
 2 1.00 (0.89,1.11) 0.88 (0.77,1.01) 1.04 (0.94,1.16) 1.07 (0.97,1.19) 1.04 (0.94,1.16) 1.08 (0.97,1.20) 1.01 (0.88,1.15)
 3 or more 1.09 (0.90,1.33) 1.00 (0.81,1.22) 1.03 (0.85,1.25) 1.06 (0.87,1.29) 0.96 (0.80,1.16) 1.07 (0.90,1.28) 1.01 (0.79,1.28)
 Unknown/missing 1.51 (0.77,2.99) 1.16 (0.52,2.60) 1.01 (0.51,2.01) 1.31 (0.65,2.63) 1.14 (0.49,2.70) 1.11 (0.45,2.75) 0.70 (0.41,1.19)
Child’s place of delivery
 Health facility Ref. Ref. Ref. Ref. Ref. Ref. Ref.
 Home 0.48 (0.42,0.54) 0.38 (0.33,0.43) 0.77 (0.71,0.84) 0.77 (0.71,0.84) 0.78 (0.71,0.85) 0.75 (0.69,0.82) 0.77 (0.69,0.86)
Year of birth
 2013 Ref. Ref. Ref. Ref. Ref. Ref. Ref.
 2014 1.14 (1.03,1.27) 1.17 (1.02,1.34) 1.27 (1.14,1.41) 1.19 (1.07,1.31) 1.33 (1.20,1.49) 1.42 (1.27,1.58) 0.92 (0.83,1.02)
 2015 1.00 (0.89,1.12) 1.11 (0.97,1.28) 1.18 (1.06,1.32) 1.07 (0.96,1.19) 1.22 (1.09,1.37) 1.30 (1.16,1.45)

Notes: Adjusted hazard ratios (aHR) and their 95% confidence intervals (CI) obtained from cox proportional hazard models. Survival data analyzed using weights to account for the complex sampling design of the TDHS-MIS. Boldface indicates statistical significance (p<0.05).

To account for changes in guidelines in January 2013, coverage and timeliness for the pneumococcal (PCV1-PCV3) and rotavirus (Rota1-Rota2) vaccine series were not assessed for children born prior to 2013.

Births in 2012 (229) and 2016 (40) were recoded to 2013 and 2015, respectively.

#

N=1,861 children born in 2015 and 2016 were excluded from the measles model because, at the time of data collection, most of those children in the TDHS-MIS sample were not yet age eligible for the measles vaccine.

TDHS-MIS: Tanzania Demographic and Health Survey and Malaria Indicator Survey.